Nicolás Balado
Angel investor in Ourense
Ourense, Galicia
Nicolás Balado, Angel investor in Ourense is an active investor based in Ourense, Galicia. This profile covers what Nicolás Balado backs, at which stage, and how founders can reach out in 2026.
- Investor type
- AngelVCPEFinance OperatorOperator
- Stages
- Seed
- Invests in
- HR & Future of Work
- Location
- Ourense, Galicia
- Typical check
- $250K
- Past investments
- 1
Notable investments
How to reach Nicolás Balado
Angels and operators like Nicolás Balado reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Nicolás Balado
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Nicolás Balado invest in?
Nicolás Balado invests in HR & Future of Work, typically at Seed. Match your sector and stage, then reach out with a personalized pitch.
What stage does Nicolás Balado invest at?
Nicolás Balado typically invests at Seed. Lead with traction that fits the stage when you reach out.
What is Nicolás Balado's typical check size?
Nicolás Balado typically writes checks around $250K. Use it as a signal for whether your raise fits their stage.
How do I contact Nicolás Balado?
Unlock Nicolás Balado's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.